Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
252 participants
INTERVENTIONAL
2004-05-31
2010-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Adaptive Treatment for Alcohol and Cocaine Dependence
NCT01032135
Telephone-Based Continuing Care for Alcohol Dependence
NCT02030093
Using Telephone Technology to Prevent Relapse After Alcoholism Treatment
NCT00132795
Integration of Neurofunctional Phenotyping Into Investigation of CBT4CBT for AUD
NCT06190236
Attentional Control Training for Treating Alcohol Use Disorder
NCT05102942
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
FACTORIAL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
TAU
No interventions assigned to this group
Telephone Monitoring
Telephone Monitoring and Feedback
In addition to attending IOP, participants receive phone contact from our counselors but only to receive a monitoring assessment. There is no feedback or counseling from study staff in this condition.
Telephone Monitoring and Counseling
Telephone Monitoring and Counseling
In addition to attending IOP, participants have phone contact with study counselors, which includes monitoring, feedback, and counseling.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Telephone Monitoring and Feedback
In addition to attending IOP, participants receive phone contact from our counselors but only to receive a monitoring assessment. There is no feedback or counseling from study staff in this condition.
Telephone Monitoring and Counseling
In addition to attending IOP, participants have phone contact with study counselors, which includes monitoring, feedback, and counseling.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* qualify for a current DSM-IV diagnosis of alcohol dependence (during the month prior to entrance into the IOP or detoxification program prior to IOP);
* willingness to participate in research and be randomized;
* 4th grade reading level (as determined by the Slosson Oral Reading Test; Slosson, 1963);
* able to provide the names of several informants who will know his/her whereabouts during the follow-up period
Exclusion Criteria
* IV heroin use during the past year;
* anticipated involvement in other forms of intensive treatment (e.g., inpatient) during the 6-month period after enrollment.
18 Years
70 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Pennsylvania
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
University of Pennsylvania
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
James McKay, Ph. D.
Role: PRINCIPAL_INVESTIGATOR
University of Pennsylvania
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Pennsylvania
Philadelphia, Pennsylvania, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
708753
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.